PositoAI/ US/ Wave Life Sciences, Inc.

Wave Life Sciences, Inc.

NasdaqGM: WVE · Healthcare

Positivity Index

#1,243 / 6,774

Global

#253 / 4,000

United States

Positivity Score

23,025

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

Wave Life Sciences, Inc. — Overview & Financial Snapshot

Wave Life Sciences, Inc. (NasdaqGM: WVE) is a Healthcare company, ranked #1,243 of 6,774 companies globally and #253 of 4,000 in United States on PositoAI, with a Positivity Score of 23,025. Its market capitalisation is ₹6,230.85 Cr ($660.11M), P/E ratio is -3.1 and P/B ratio is 1.46. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington's disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.

P/B Ratio 1.46

P/E Ratio -3.1

D/E Ratio 0.10

ROE -67.42%

Owes vs Owns ? 0.19× Low $0.19 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-101.94$-1.08

Forward EPS ₹-110.12$-1.17

Beta -1.43

Market Cap ₹6,230.85 Cr$660.11M

What these numbers mean →

What does Wave Life Sciences, Inc. do?

What is Wave Life Sciences, Inc.'s P/E and P/B ratio?

Wave Life Sciences, Inc. has a P/E ratio of -3.1 and a P/B ratio of 1.46.

What is Wave Life Sciences, Inc.'s debt-to-equity ratio?

Wave Life Sciences, Inc. has a debt-to-equity ratio of 0.10.

How much does Wave Life Sciences, Inc. owe compared with what it owns?

Wave Life Sciences, Inc. owes $0.19 for every $1 it owns (balance sheet Jun 2026), which is low.

What is Wave Life Sciences, Inc.'s Positivity rank?

Wave Life Sciences, Inc. is ranked #1,243 of 6,774 companies globally and #253 of 4,000 in United States on PositoAI, with a Positivity Score of 23,025.

Does Wave Life Sciences, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Wave Life Sciences, Inc..

Where can I read the latest news about Wave Life Sciences, Inc.?

Recent headlines about Wave Life Sciences, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Wave Life Sciences, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Wave Life Sciences, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.